FR2350098A1 - Procede de preparation de produits contenant des polyhydroxyphenyl-chromanones - Google Patents

Procede de preparation de produits contenant des polyhydroxyphenyl-chromanones

Info

Publication number
FR2350098A1
FR2350098A1 FR7713365A FR7713365A FR2350098A1 FR 2350098 A1 FR2350098 A1 FR 2350098A1 FR 7713365 A FR7713365 A FR 7713365A FR 7713365 A FR7713365 A FR 7713365A FR 2350098 A1 FR2350098 A1 FR 2350098A1
Authority
FR
France
Prior art keywords
polyhydroxyphenyl
chromanones
products containing
preparing products
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713365A
Other languages
English (en)
Other versions
FR2350098B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inverni Della Beffa SpA
Original Assignee
Inverni Della Beffa SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inverni Della Beffa SpA filed Critical Inverni Della Beffa SpA
Publication of FR2350098A1 publication Critical patent/FR2350098A1/fr
Application granted granted Critical
Publication of FR2350098B1 publication Critical patent/FR2350098B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/40—Separation, e.g. from natural material; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
FR7713365A 1976-05-05 1977-05-03 Procede de preparation de produits contenant des polyhydroxyphenyl-chromanones Granted FR2350098A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB18415/76A GB1554662A (en) 1976-05-05 1976-05-05 Polyhydroxyphenylchromanones

Publications (2)

Publication Number Publication Date
FR2350098A1 true FR2350098A1 (fr) 1977-12-02
FR2350098B1 FR2350098B1 (fr) 1980-02-01

Family

ID=10112059

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713365A Granted FR2350098A1 (fr) 1976-05-05 1977-05-03 Procede de preparation de produits contenant des polyhydroxyphenyl-chromanones

Country Status (8)

Country Link
US (1) US4081529A (fr)
JP (1) JPS52134010A (fr)
BE (1) BE854062A (fr)
DE (1) DE2719581A1 (fr)
FR (1) FR2350098A1 (fr)
GB (1) GB1554662A (fr)
GR (1) GR59860B (fr)
PT (1) PT66489B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0722719A1 (fr) * 1995-01-18 1996-07-24 MADAUS Aktiengesellschaft Procédé de fabrication de préparations à base de flavano-lignanes
EP2742954A1 (fr) * 2012-12-17 2014-06-18 INDENA S.p.A. Formulation aqueuse de silymarine

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
DE19756677A1 (de) * 1997-12-19 1999-06-24 Krewel Meuselbach Gmbh Arzneipflanzentrockenextrakte
DE19915178A1 (de) 1999-04-03 2000-10-05 Univ Mainz Johannes Gutenberg Hepatitis C Virus Zellkultursystem
CZ292832B6 (cs) * 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Způsob přípravy silymarinu se zvýšenou rozpustností
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
CZ2008407A3 (cs) * 2008-06-26 2009-08-26 Agra Group, A. S. Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy
CN109223721A (zh) * 2018-09-28 2019-01-18 江苏天美健大自然生物工程有限公司 磷脂水飞蓟维生素e组合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089818A (en) * 1960-06-02 1963-05-14 Baxter Laboratories Inc Water dispersible antibiotics
US3673163A (en) * 1970-06-16 1972-06-27 Lilly Co Eli Pharmacological preparation containing an acronycine-polyvinylprrolidone coprecipitate
DE2416302B2 (de) * 1974-04-04 1978-02-02 Dr. Madaus & Co, 5000 Köln Dimeres sowie trimeres silybin und deren n-methylglucaminsalz und verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0722719A1 (fr) * 1995-01-18 1996-07-24 MADAUS Aktiengesellschaft Procédé de fabrication de préparations à base de flavano-lignanes
EP2742954A1 (fr) * 2012-12-17 2014-06-18 INDENA S.p.A. Formulation aqueuse de silymarine
WO2014095485A1 (fr) * 2012-12-17 2014-06-26 Indena S.P.A. Formulation aqueuse de silymarine

Also Published As

Publication number Publication date
DE2719581A1 (de) 1977-11-24
JPS52134010A (en) 1977-11-09
JPS5725006B2 (fr) 1982-05-27
US4081529A (en) 1978-03-28
GR59860B (en) 1978-03-07
PT66489B (fr) 1978-09-29
BE854062A (fr) 1977-08-16
GB1554662A (en) 1979-10-24
PT66489A (fr) 1977-05-01
FR2350098B1 (fr) 1980-02-01

Similar Documents

Publication Publication Date Title
BE828945A (fr) Procede d'obtention de produits alimentaires du type "chips"
RO67390A (fr) Procede pour -a preparation des 2-tetrahydrofurfuryle-6,7-benzo-morphanes 5,9-betha-disubstitus
BE818574A (fr) Procede de preparation d'un produit alimentaire
BE851536A (fr) Procede de frittage de produits ceramiques
ZA787368B (en) N-substituted w-aminoalkanoyl-w-aminoalkanoic acids,their use and process for their production as well as pharmaceutical products containing these compounds
BE832175A (fr) Procede de preparation de produits alimentaires
BE843019A (fr) Procede de preparation de produits alimentaires.
BE869744A (fr) Procede de preparation de produits alimentaires
FR2350098A1 (fr) Procede de preparation de produits contenant des polyhydroxyphenyl-chromanones
RO68712A (fr) Procede d'obtention des riphamicines
FR2282403A1 (fr) Procede de preparation de percarbonate ou de perborate de sodium
RO64606A (fr) Procede pour la preparation des 6-methylergolines-8,8-disubstituees
BE836194A (fr) Produit alimentaire et procede pour la preparation
BE813169A (fr) Procede de preparation des 3-fluorocephalosporines
LU80346A1 (fr) Procede de preparation d'un produit alimentaire ameliore
FR2325658A1 (fr) Procede de preparation de produits de polyaddition renfermant du phosphore
FR2326531A1 (fr) Procede pour recuperer des produits d'ensimage
FR2317251A1 (fr) Procede de preparation de produits ceramiques
BE832208A (fr) Procede de preparation de polyisocyanurates alveulaires auto-exitu????? contenant des groupes urethane
FR2315861A1 (fr) Procede de realisation de saccharose comprenant des produits volatils
FR2307627A1 (fr) Procede de moulage de produits contenant des liants hydrauliques
BE870619A (fr) Procede de production de produits polycondenses
BE859018A (fr) Procede de conditionnement de produits alimentaires
FR2298565A1 (fr) Procede de produ
FR2327927A1 (fr) Procede pour fabriquer des emballages etanches sous vide, particulierement des emballages contenant des produits alimentaires

Legal Events

Date Code Title Description
ST Notification of lapse